145 related articles for article (PubMed ID: 8141723)
1. GUSTO II trial.
Aylward P
Aust N Z J Med; 1993 Dec; 23(6):766-8. PubMed ID: 8141723
[TBL] [Abstract][Full Text] [Related]
2. Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty.
Cannon CP; Braunwald E
J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):30S-37S. PubMed ID: 7775712
[TBL] [Abstract][Full Text] [Related]
3. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
Carswell CI; Plosker GL
Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.
Bahit MC; Topol EJ; Califf RM; Armstrong PW; Criger DA; Hasselblad V; Betriu A; Hirsh J; Ardissino D; Granger CB
J Am Coll Cardiol; 2001 Mar; 37(4):1001-7. PubMed ID: 11263599
[TBL] [Abstract][Full Text] [Related]
5. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes.
Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators
N Engl J Med; 1996 Sep; 335(11):775-82. PubMed ID: 8778585
[TBL] [Abstract][Full Text] [Related]
6. Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction.
Antman EM; McCabe CH; Braunwald E
Am Heart J; 2002 Feb; 143(2):229-34. PubMed ID: 11835024
[TBL] [Abstract][Full Text] [Related]
7. Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial.
Yusuf S
Am J Cardiol; 1999 Sep; 84(5A):20M-25M. PubMed ID: 10505539
[TBL] [Abstract][Full Text] [Related]
8. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
Metz BK; White HD; Granger CB; Simes RJ; Armstrong PW; Hirsh J; Fuster V; MacAulay CM; Califf RM; Topol EJ
J Am Coll Cardiol; 1998 Jun; 31(7):1493-8. PubMed ID: 9626825
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
[TBL] [Abstract][Full Text] [Related]
11. Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.
Antman EM
Circulation; 1994 Oct; 90(4):1624-30. PubMed ID: 7923644
[TBL] [Abstract][Full Text] [Related]
12. [Hirudin is superior to heparin in reducing cardiovascular mortality, infarct and refractory angina in patients with unstable angina or myocardial infarct without elevation of the ST tract].
Franzosi MG
Ital Heart J Suppl; 2000 Sep; 1(9):1210-2. PubMed ID: 11140295
[No Abstract] [Full Text] [Related]
13. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
Direct Thrombin Inhibitor Trialists' Collaborative Group
Lancet; 2002 Jan; 359(9303):294-302. PubMed ID: 11830196
[TBL] [Abstract][Full Text] [Related]
14. Hirudin and hirudin analogues as new anticoagulant agents.
Pineo GF; Hull RD
Curr Opin Hematol; 1995 Sep; 2(5):380-5. PubMed ID: 9372023
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.
Circulation; 1994 Oct; 90(4):1631-7. PubMed ID: 7923645
[TBL] [Abstract][Full Text] [Related]
16. Potential advantages of direct-acting thrombin inhibitors.
Philippides GJ; Loscalzo J
Coron Artery Dis; 1996 Jul; 7(7):497-507. PubMed ID: 8913677
[No Abstract] [Full Text] [Related]
17. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.
Topol EJ; Fuster V; Harrington RA; Califf RM; Kleiman NS; Kereiakes DJ; Cohen M; Chapekis A; Gold HK; Tannenbaum MA
Circulation; 1994 Apr; 89(4):1557-66. PubMed ID: 8149521
[TBL] [Abstract][Full Text] [Related]
18. Direct thrombin inhibition superior to heparin during and after thrombolysis: dose, duration, and drug.
Chesebro JH
Circulation; 1997 Oct; 96(7):2118-20. PubMed ID: 9337177
[No Abstract] [Full Text] [Related]
19. Pharmacological properties of hirudin and its derivatives. Potential clinical advantages over heparin.
Monreal M; Costa J; Salva P
Drugs Aging; 1996 Mar; 8(3):171-82. PubMed ID: 8720743
[TBL] [Abstract][Full Text] [Related]
20. Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators.
Fu Y; Chang WC; Mark D; Califf RM; Mackenzie B; Granger CB; Topol EJ; Hlatky M; Armstrong PW
Circulation; 2000 Sep; 102(12):1375-81. PubMed ID: 10993855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
